NuVasive, Inc. (NUVA) News Headlines

▮ More

Date

Headline

9/12/2022 10:40:02 AM NuVasive To Present At Morgan Stanley Global Healthcare Conference; Webcast At 11:40 AM ET

9/7/2022 2:10:08 PM NuVasive To Present At Wells Fargo Healthcare Conference; Webcast At 3:10 PM ET

8/4/2022 5:25:05 AM VNDA On Watch, NUVA Q2 Results Miss Estimates, MRTX Awaits FDA Decision...

8/3/2022 4:18:49 PM NuVasive, Inc. Q2 Earnings Summary

8/3/2022 4:14:40 PM NuVasive Q2 Loss/share $0.02 Vs. Profit $0.03 Year Ago

8/3/2022 3:00:16 PM NuVasive Q2 22 Earnings Conference Call At 4:30 PM ET

5/4/2022 4:30:29 PM NuVasive Lifts FY22 Outlook

5/4/2022 4:14:35 PM NuVasive, Inc. (NUVA) Has Raised Its 2022 EPS Estimate To 2.15 - 2.45 From 2.05 - 2.35

5/4/2022 4:12:31 PM NuVasive, Inc. Q1 Earnings Summary

5/4/2022 4:11:05 PM NuVasive Q1 EPS $0.35 Vs. Loss $0.15 Year Ago

5/4/2022 3:00:34 PM NuVasive Q1 22 Earnings Conference Call At 4:30 PM ET

2/23/2022 4:25:23 PM NuVasive Reports Q4 Loss Per Share Of $0.71 Vs. EPS Of $0.03 Last Year

2/23/2022 4:18:23 PM NuVasive, Inc. Q4 Earnings Summary

2/23/2022 2:30:09 PM NuVasive Q4 21 Earnings Conference Call At 4:30 PM ET

1/31/2022 4:11:50 PM NuVasive Appoints Andrew Morton As Chief Human Resources Officer

1/12/2022 2:00:08 PM NuVasive To Present At J.P. Morgan Healthcare Conference; Webcast At 3:00 PM ET

1/5/2022 7:07:50 AM NuVasive: FDA Approves Expanded Indications Of Attrax Putty - Quick Facts

1/5/2022 7:02:19 AM NuVasive Gets FDA Clearance For Expanded Indications Of Use For Attrax Putty With Thoracolumbar Interbody Portfolio

11/9/2021 4:18:59 PM NuVasive, Inc. (NUVA) Has Raised Its 2021 EPS Estimate To 1.73 - 1.83 From 2.25 - 2.35

11/9/2021 4:18:13 PM NuVasive, Inc. (NUVA) Has Raised Its 2021 Revenue Estimate To $1.132 - $1.142 Bln From $1.190 - $1.210 Bln

Nuvasive, Inc. (NUVA)